These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
24. A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer. Shitara K; Sawaki A; Matsuo K; Kondo C; Takahari D; Ura T; Tajika M; Niwa Y; Muro K Int J Clin Oncol; 2013 Jun; 18(3):539-46. PubMed ID: 22552360 [TBL] [Abstract][Full Text] [Related]
25. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer. Konishi T; Shinozaki E; Murofushi K; Taguchi S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Suenaga M; Chino A; Kawachi H; Yamamoto N; Ishikawa Y; Oguchi M; Ishizuka N; Ueno M; Yamaguchi K Ann Surg Oncol; 2019 Aug; 26(8):2507-2513. PubMed ID: 30963400 [TBL] [Abstract][Full Text] [Related]
26. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
27. Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer. Wu HC; Lin WL; Lin CL; Lin CY; Chen SW; Chen YX; Chen CH; Lee SW; Chen SH; Tsao CJ; Huang WT; Guo HR Aging (Albany NY); 2021 Jul; 13(13):17337-17348. PubMed ID: 34226296 [TBL] [Abstract][Full Text] [Related]
28. Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial. Yu JI; Lim DH; Ahn YC; Lee J; Kang WK; Park SH; Park JO; Park YS; Lim HY; Kim ST; Kim S; Sohn TS; Choi MG; Bae JM; Nam H Radiother Oncol; 2015 Oct; 117(1):171-7. PubMed ID: 26299196 [TBL] [Abstract][Full Text] [Related]
29. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis. He Q; Ma L; Li Y; Li G BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354 [TBL] [Abstract][Full Text] [Related]
30. Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy? Chan AK; Wong AO; Jenken DA Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1413-9. PubMed ID: 20338475 [TBL] [Abstract][Full Text] [Related]
31. Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma. Ahn D; Sohn JH; Kim JH; Lee JE; Park SH; Kim JC Ear Nose Throat J; 2016 Feb; 95(2):E34-42. PubMed ID: 26930342 [TBL] [Abstract][Full Text] [Related]
32. [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy]. Mihara K; Yamashiro N; Nishiya S; Kemmochi T; Ito Y; Egawa T; Nagashima A Gan To Kagaku Ryoho; 2014 Nov; 41(12):2358-60. PubMed ID: 25731522 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. Kollmannsberger C; Budach W; Stahl M; Schleucher N; Hehr T; Wilke H; Schleicher J; Vanhoefer U; Jehle EC; Oechsle K; Trarbach T; Boehlke I; Kanz L; Hartmann JT; Bokemeyer C Ann Oncol; 2005 Aug; 16(8):1326-33. PubMed ID: 15919686 [TBL] [Abstract][Full Text] [Related]
34. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trial. Chen J; Xiong J; Wang J; Zheng L; Gao Y; Guan Z Asia Pac J Clin Oncol; 2018 Oct; 14(5):e310-e316. PubMed ID: 29372626 [TBL] [Abstract][Full Text] [Related]
35. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer. Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346 [TBL] [Abstract][Full Text] [Related]
36. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer. Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524 [TBL] [Abstract][Full Text] [Related]
37. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma. Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512 [TBL] [Abstract][Full Text] [Related]
38. A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer. Ychou M; Astre C; Rouanet P; Fabre JM; Saint-Aubert B; Domergue J; Ribard D; Ciurana AJ; Janbon C; Pujol H Eur J Cancer; 1996 Oct; 32A(11):1933-7. PubMed ID: 8943677 [TBL] [Abstract][Full Text] [Related]
39. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial. Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of oxaliplatin plus 5-fluorouracil/leucovorin calcium combined with concurrent radiotherapy for local advanced gastric cancer]. Shao ZY; Zhang JD Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2547-9. PubMed ID: 19080647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]